Viewing Study NCT06732895


Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2026-02-17 @ 6:50 PM
Study NCT ID: NCT06732895
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
Sponsor: Ascendis Pharma A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module